mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer

Authors

Harrison Cash, National Institutes of Deafness and Other Communication Disorders
Sujay Shah, National Institutes Deafness and Other Communication Disorders
Ellen Moore, National Institutes Deafness and Other Communication Disorders
Andria Caruso, Walter Reed National Military Medical Center
Ravindra Uppaluri, Washington University School of Medicine in St. Louis
Carter Van Waes, National Institutes of Deafness and Other Communication Disorders
Clint Allen, Johns Hopkins School of Medicine

Journal

Oncotarget

Publication Date

2015

Volume

6

Issue

34

Inclusive Pages

36400-17

Document Type

Open Access Publication

DOI

10.18632/oncotarget.5063

Rights and Permissions

Cash, H., Shah, S., Moore, E., Caruso, A., Uppaluri, R., Waes, C., & Allen, C. (2015). mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer. Oncotarget, 6(34), 36400-36417. doi: 10.18632/oncotarget.5063. Copyright: © Cash et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Cash, Harrison; Shah, Sujay; Moore, Ellen; Caruso, Andria; Uppaluri, Ravindra; Waes, Carter Van; and Allen, Clint, "mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer." Oncotarget. 6, 34. 36400-17. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4396